Proteomic Data Commons: A Resource for Proteogenomic Analysis
Hall C, North Terrace, Adelaide,
South Australia 5000,
Australia
Proteomic Data Commons collaborator, Dr. Chris Kinsinger, will present "Proteomic Data Commons: a resource for proteogenomic analysis" during the Proteogenomics Panel at 3:15 p.m. Australian time (1:45 a.m. ET).
The NCI Cancer Research Data Common's Proteomic Data Commons (PDC) PDC aims to make cancer-related proteomic datasets accessible to the public, providing researchers the ability to find and analyze proteomic data across a variety of tumor types. Currently, the PDC houses data, supported by a large collection of metadata attributes, for ~20 datasets produced by Clinical Proteomic Tumor Analysis Consortium (CPTAC) and other large-scale cancer research programs,with most of the data sets having corresponding genomic data and images available in the Genomic Data Commons and The Cancer Imaging Archive.
For additional information about the presentation, refer to the presentation abstract.
Dr. Kinsinger is a program director for the Office of Cancer Clinical Proteomics Research within the Center for Strategic Scientific Initiatives. R focuses on the expansion and coordination of open data access and programmatic goals involving mass spectrometry, informatics, and biospecimens. In this role, he works with NCI staff and investigators to optimize proteomics technology, establish policies for sharing data and biospecimens, and generally improve the quality and reliability of proteomic measurements, including supporting the development of the NCI Cancer Research Data Common's Proteomic Data Commons.
Dr. Kinsinger completed postdoctoral training at NIST, where he researched fragmentation pathways of peptide ions in mass spectrometry. He holds a Ph.D. degree in chemistry (2004) from the University of Minnesota.
Upcoming Events
- Cancer Research Data Commons and Other NCI Infrastructures in Support of Data ScienceSeptember 19, 2021AttentiveChrome: Deep Learning for Predicting Gene Expression from Histone ModificationsSeptember 22, 2021“Le Grand et Le Petit”: Splicing Factors SF3B1 and SUGP1 and Their Cancer Mutations Leading to Aberrant Acceptor UsageSeptember 22, 2021The Future of Clinical Trial Data Sharing.... The Art of The PossibleSeptember 23, 2021Genomic Data Commons Single Cell RNA-Seq SupportSeptember 27, 2021Virtual Workshop on Next-Generation Sequencing and Radiomics: Resource Requirements for Acceleration of Clinical Applications Including AISeptember 29, 2021 - September 30, 2021